Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
International Journal of Medicinal Mushrooms
Fator do impacto: 1.423 FI de cinco anos: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN On-line: 1940-4344

Volumes:
Volume 21, 2019 Volume 20, 2018 Volume 19, 2017 Volume 18, 2016 Volume 17, 2015 Volume 16, 2014 Volume 15, 2013 Volume 14, 2012 Volume 13, 2011 Volume 12, 2010 Volume 11, 2009 Volume 10, 2008 Volume 9, 2007 Volume 8, 2006 Volume 7, 2005 Volume 6, 2004 Volume 5, 2003 Volume 4, 2002 Volume 3, 2001 Volume 2, 2000 Volume 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushr.v8.i4.60
pages 351-360

Biotechnological Potential of Mushrooms: Drugs and Dye Production

Girish Tidke
Department of Biotechnology, Amravati Univarsity, Amravati, Maharashtra - 444602, Iindia
Mahendra K. Rai
Department of Biotechnology, SGB Amravati University, Amravati, Maharashtra-444 602, India

RESUMO

Mushrooms are a new and emerging source of potent pharmaceutical products. Medicinal mushrooms are being used in countries such as China, Japan, Korea, India, and also Russia, and now Western countries have also realized the curative properties of mushrooms. Ganoderma lucidum, Lentinus edodes, Trametes versicolor, Schizophyllum commune, Flammulina velutipes, Pleurotus ostreatus, Agaricus bisporus, A. brasiliensis Pholiota nameko, Tricholoma matsutake, Auricularia auricula, and Grifola frondosa possess wide range of bioactivities, e.g., anticancerous, antibacterial, antiviral, antifungal, antidiabitic, and anti-inflammatory. These are also used in cardiovascular disorders. Usually, mushrooms are administered orally or intraperitoneally. Mushrooms are also used for the production of dyes. These include Agaricus spp., Coriolopsis spp., Daedalea sterioides, Ganoderma applanatum, G. curtissi, G. spruci, G. resupinacium, Hexagonia hirta, H. tenicis, Laetiporus sulphureus, Lenzites betulina, Lycoperdon imbricatum, Oxiporus corticola, Phaeolus schwenitzi, Polyporus alveolus, P. brumalis, and Schizopora spp. There is a need to screen these mushrooms for their bioactivity and also for dye production. The present review aims to discuss the therapeutic activity and dye-producing properties of mushrooms.


Articles with similar content:

Medicinal Properties of Substances Occurring in Higher Basidiomycetes Mushrooms: Current Perspectives (Review)
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis
Medicinal Mushrooms of Southwest Siberia
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Tamara V. Teplyakova, Irina A. Gorbunova, N. B. Perova
Evaluation of the Antibacterial Activity of 75 Mushrooms Collected in the Vicinity of Oxford, Ohio (USA)
International Journal of Medicinal Mushrooms, Vol.21, 2019, issue 2
Faizule Hassan, Luis A. Actis, Christine M. Kinstedt, Jana L. Abdul-Samad, Shuisong Ni, Taylor L. Becker, Michael A. Kennedy
Bioactive Substances in Hericium erinaceus (Bull.: Fr.) Pers. (Yamabushitake), and Its Medicinal Utilization
International Journal of Medicinal Mushrooms, Vol.1, 1999, issue 2
Takashi Mizuno
Therapeutic Effects of Substances Occurring in Higher Basidiomycetes Mushrooms: A Modern Perspective
Critical Reviews™ in Immunology, Vol.19, 1999, issue 1
Solomon P. Wasser, Alexander L. Weis